Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Fractyl Health (GUTS) Shares Outstanding (Weighted Average) (2023 - 2025)

Fractyl Health (GUTS) has disclosed Shares Outstanding (Weighted Average) for 3 consecutive years, with $54.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Outstanding (Weighted Average) rose 29.48% year-over-year to $54.2 million, compared with a TTM value of $54.2 million through Sep 2025, up 29.48%, and an annual FY2024 reading of $43.5 million, up 1992.01% over the prior year.
  • Shares Outstanding (Weighted Average) was $54.2 million for Q3 2025 at Fractyl Health, up from $49.0 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $54.2 million in Q3 2025 and bottomed at $2.1 million in Q1 2023.
  • Average Shares Outstanding (Weighted Average) over 3 years is $29.4 million, with a median of $41.9 million recorded in 2024.
  • The sharpest move saw Shares Outstanding (Weighted Average) skyrocketed 2206.23% in 2024, then increased 2.2% in 2025.
  • Year by year, Shares Outstanding (Weighted Average) stood at $2.1 million in 2023, then soared by 1992.01% to $43.5 million in 2024, then increased by 24.58% to $54.2 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for GUTS at $54.2 million in Q3 2025, $49.0 million in Q2 2025, and $48.9 million in Q1 2025.